Contact information
Research groups
Amelia Seabold
DPhil in Translational Health Sciences
Amelia Seabold is a first year DPhil student in Translational Health Sciences. She completed her undergraduate studies and masters in city planning at Massachusetts Institute of Technology. Her research focuses on bridging the gap between academic research and practice by examining the implementation of medical diagnostics in LMICs in sub-Saharan Africa.
Her DPhil work aims to assess the feasibility of implementing a nationwide newborn screening program for sickle cell disease (SCD) in Tanzania, where SCD prevalence is particularly high. She plans to use qualitative methods including interviews and observations to better understand how a newborn screening program could be integrated into Tanzania's current health system.
Amelia has a background in wet lab biology, working on multiple CRISPR-Cas projects including the development of a low-cost point-of-care sickle cell disease diagnostic based on Cas13 in the Li Lab at the University of California, San Diego. Her previous work has also included research on the community-based responses to COVID-19 in slums and informal settlements of Freetown, Sierra Leone; Buenos Aires, Argentina; and Ahmedabad, India, as well as the effect of COVID-19 on the livelihoods of slums dwellers in Masvingo, Zimbabwe. [see publications]